Independent GLP-1 journalism · by LunaRx

The GLP-1 newsletter trusted for evidence, not hype.

Clear, clinician-reviewed coverage of semaglutide, tirzepatide, weight science, and access — delivered to your inbox.

  • Reviewed by registered nurses
  • Cited to clinical trials & FDA data
  • No hype. No miracle claims.

Explore by topic

Featured

Cost & Access

Semaglutide vs. Tirzepatide: The Real 2025 Cost Breakdown

Brand, compounded, insurance, and cash-pay — what GLP-1 medications actually cost this year, and how to avoid overpaying.

Read the analysis →

Latest coverage

The 2025 GLP-1 Cost Index

Interactive pricing across brand, compounded, and cash-pay options — updated quarterly from pharmacy data. Our most-shared resource.

Explore the index →